ICER Study On Coverage 'Fairness' Could Inform Manufacturer Pricing vs Benefit Design Debate
Study will look at prior authorization, step therapy and required medication switching for drugs considered to be reasonably priced.
Study will look at prior authorization, step therapy and required medication switching for drugs considered to be reasonably priced.